Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
17743 | 521 | 28.8 | 49% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1701 | 6131 | INTERNATIONAL JOURNAL OF HYPERTHERMIA//ISOLATED LIMB PERFUSION//LONIDAMINE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PEPTICHEMIO | Author keyword | 8 | 100% | 1% | 5 |
2 | ALKYLATING PEPTIDES | Author keyword | 3 | 100% | 1% | 3 |
3 | HUMAN MYELOMA CELLS | Author keyword | 3 | 60% | 1% | 3 |
4 | CELL CYCLE FLOW | Author keyword | 2 | 67% | 0% | 2 |
5 | INT BIOANAL BUSINESS SUPPORT | Address | 2 | 67% | 0% | 2 |
6 | PREDNIMUSTINE | Author keyword | 2 | 31% | 1% | 5 |
7 | NITROGEN MUSTARDS | Author keyword | 2 | 18% | 2% | 9 |
8 | LEUKERAN | Author keyword | 1 | 100% | 0% | 2 |
9 | MF13 | Author keyword | 1 | 100% | 0% | 2 |
10 | 24 HOUR CONTINUOUS INFUSION | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PEPTICHEMIO | 8 | 100% | 1% | 5 | Search PEPTICHEMIO | Search PEPTICHEMIO |
2 | ALKYLATING PEPTIDES | 3 | 100% | 1% | 3 | Search ALKYLATING+PEPTIDES | Search ALKYLATING+PEPTIDES |
3 | HUMAN MYELOMA CELLS | 3 | 60% | 1% | 3 | Search HUMAN+MYELOMA+CELLS | Search HUMAN+MYELOMA+CELLS |
4 | CELL CYCLE FLOW | 2 | 67% | 0% | 2 | Search CELL+CYCLE+FLOW | Search CELL+CYCLE+FLOW |
5 | PREDNIMUSTINE | 2 | 31% | 1% | 5 | Search PREDNIMUSTINE | Search PREDNIMUSTINE |
6 | NITROGEN MUSTARDS | 2 | 18% | 2% | 9 | Search NITROGEN+MUSTARDS | Search NITROGEN+MUSTARDS |
7 | LEUKERAN | 1 | 100% | 0% | 2 | Search LEUKERAN | Search LEUKERAN |
8 | MF13 | 1 | 100% | 0% | 2 | Search MF13 | Search MF13 |
9 | 24 HOUR CONTINUOUS INFUSION | 1 | 50% | 0% | 1 | Search 24+HOUR+CONTINUOUS+INFUSION | Search 24+HOUR+CONTINUOUS+INFUSION |
10 | 3 THIOPHENE ACETIC ACID | 1 | 50% | 0% | 1 | Search 3+THIOPHENE+ACETIC+ACID | Search 3+THIOPHENE+ACETIC+ACID |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PEPTICHEMIO | 9 | 67% | 2% | 8 |
2 | L PHENYLALANINE MUSTARD | 5 | 25% | 3% | 18 |
3 | PREDNIMUSTINE | 4 | 38% | 2% | 8 |
4 | ADENINE ADDUCTS | 4 | 46% | 1% | 6 |
5 | NITROGEN MUSTARDS | 4 | 13% | 5% | 26 |
6 | LEO 1031 | 3 | 100% | 1% | 3 |
7 | PHENYLACETIC ACID MUSTARD | 3 | 100% | 1% | 3 |
8 | FLUOROPHENYLALANINE ETHYL ESTER | 2 | 50% | 1% | 3 |
9 | CARRIER AMINO ACIDS | 1 | 100% | 0% | 2 |
10 | L M SARCOLYSIN | 1 | 100% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
HIGH-DOSE INTRAVENOUS MELPHALAN - A REVIEW | 1995 | 116 | 71 | 28% |
DNA adducts from chemotherapeutic agents | 1996 | 158 | 97 | 15% |
THE SYSTEMIC ADMINISTRATION OF INTRAVENOUS MELPHALAN | 1988 | 75 | 52 | 33% |
PHARMACOKINETICS OF ALKYLATING-AGENTS | 1993 | 44 | 99 | 39% |
DNA-DAMAGE AND MUTAGENESIS INDUCED BY NITROGEN MUSTARDS | 1994 | 138 | 76 | 14% |
MECHANISMS OF ACTION OF, AND MODES OF RESISTANCE TO, ALKYLATING-AGENTS USED IN THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES | 1992 | 52 | 39 | 21% |
Preparation and biodistribution of [I-125]Melphalan: a potential radioligand for diagnostic and therapeutic applications | 2010 | 3 | 11 | 27% |
Not too little, not too much-just right! (Better ways to give high dose melphalan) | 2014 | 0 | 81 | 33% |
METABOLISM AND REACTIONS OF ALKYLATING-AGENTS | 1987 | 48 | 153 | 29% |
The role of DNA repair in nitrogen mustard drug resistance | 2002 | 21 | 74 | 19% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INT BIOANAL BUSINESS SUPPORT | 2 | 67% | 0.4% | 2 |
2 | CRC DRUGDNA INTERACT GRP | 1 | 50% | 0.2% | 1 |
3 | ESPECIALISTA FARM HOSP | 1 | 50% | 0.2% | 1 |
4 | PHARMACOGENET PHARMACOTOXICOL | 1 | 50% | 0.2% | 1 |
5 | PROMEC CORE IL PROTE METABOL | 1 | 50% | 0.2% | 1 |
6 | PROTE MASS SPE OMETRY CEPROMA | 1 | 50% | 0.2% | 1 |
7 | RADIOISOTOPE PROD PROJECT | 1 | 50% | 0.2% | 1 |
8 | NUCLEOSIDE MASS SPE OMETRY UNIT | 1 | 12% | 1.0% | 5 |
9 | NUCLEOSIDE MASS SPECT UNIT | 1 | 22% | 0.4% | 2 |
10 | CHIM BIOCHIM TOXEN | 0 | 33% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000121613 | 2 3 4 DIARYL 5 OXO 1 2 4 TRIAZINE 6 YLIDENEACETATES//3 4 DIARYL 1 2 4 TRIAZOLO 5 CARBOXYLATES//ADEUOVIRUS |
2 | 0.0000119120 | CISPLATIN RESISTANCE//PLATINUM DNA ADDUCTS//HUMAN OVARIAN CANCER CELL LINE |
3 | 0.0000118699 | ISOLATED LIMB PERFUSION//ISOLATED LIMB INFUSION//ISOLATED HEPATIC PERFUSION |
4 | 0.0000109945 | BENDAMUSTINE//TREANDA//BENDAMUSTIN |
5 | 0.0000108926 | N N N TRIETHYLENEPHOSPHORAMIDE//THIOTEPA MERCAPTURATE//TEPA |
6 | 0.0000096549 | CELL MED//H 1 CELLS//H1 CELLS |
7 | 0.0000084312 | IFOSFAMIDE//TROFOSFAMIDE//BNP7787 |
8 | 0.0000080173 | UNITE BIOTECHNOL BIOINGN//RECHUNITE BIOTECHNOL BIOINGN//COLCHICINE BINDING SITE LIGANDS |
9 | 0.0000079882 | HOMO AZA STEROIDAL ESTERS//STEROIDAL ESTERS//HOMO AZA STEROIDS |
10 | 0.0000073071 | OSI 420//OSI 774//CAKI 1 RENAL CELL CARCINOMA |